CN102631477A - Traditional Chinese medicine for treating keratitis - Google Patents

Traditional Chinese medicine for treating keratitis Download PDF

Info

Publication number
CN102631477A
CN102631477A CN2012100907081A CN201210090708A CN102631477A CN 102631477 A CN102631477 A CN 102631477A CN 2012100907081 A CN2012100907081 A CN 2012100907081A CN 201210090708 A CN201210090708 A CN 201210090708A CN 102631477 A CN102631477 A CN 102631477A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
keratitis
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012100907081A
Other languages
Chinese (zh)
Inventor
王莲芬
董娜
渠淑敏
吴国敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012100907081A priority Critical patent/CN102631477A/en
Publication of CN102631477A publication Critical patent/CN102631477A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a traditional Chinese medicine for treating keratitis, which belongs to the technical field of traditional Chinese medicine pharmacy. The technical scheme includes that the traditional Chinese medicine for treating keratitis includes, by weight, from 3 to 15 parts of dangshen, from 2 to 10 parts of white lilac, from 3 to 15 parts of notopterygium, from 8 to 16 parts of radix rehmanniae, from 3 to 10 parts of indigowoad leaves, from 3 to 10 parts of honeysuckle, from 4 to 15 parts of radix geutianae, from 4 to 12 parts of rhizoma chuanxiong and from 2 to 9 parts of radix bupleuri. Compared with the prior art, the traditional Chinese medicine for treating keratitis can treat the keratitis of a patient, promotes physical and psychological health, is low in treatment cost, fast in curative effect and free of side effects, and is taken by the patient conveniently.

Description

A kind of Chinese medicine that is used to treat keratitis
Technical field
The present invention relates to the treatment field of pharmaceutical technology of keratitis, relate in particular to a kind of technical field of Chinese medicine that is used to treat keratitis.
Background technology
Keratitis: divide ulcerative keratitis to have another name called corneal ulcer, non-ulcerative keratitis is two types of deep keratitiss.Because of the cornea wound, antibacterial and virus are invaded the inflammation that cornea causes.Suffer from eye foreign body sensation, twinge even burn feeling are arranged.Bulbar conjunctiva surface Combination is congested, with keep in dark place, shed tears, symptoms such as eyes are opened not open, visual disorder and secretions increase.Anterior corneal surface soaks into has ulcer.Viral keratitis is common to have two kinds of herpes simplex property keratitis and herpes zoster keratitises, and its clinical symptoms also is not quite similar.Herpes simplex keratitis belongs to primary infection person, is more common in 6 months to 5 years old children's, is often caused by febrile disease; The special upper respiratory tract infection of being more common in, clinical visible blepharoedema, conjunctival congestion, cornea plays herpes; Can form ulcer,, can stay cicatrix after healing, affect one's power of vision through the normal spontaneous recovery of 2-3 week.Secondary infection; Under the risk factor effects such as normal because flu, heating, ultraviolet radiation, wound, anxious state of mind, application 17-hydroxy-11-dehydrocorticosterone, women are in the period, hide in intravital activated viral after making primary infection, arrive eye along the neuraxon; Can occur rubescent; Photophobia is shed tears, and the mill pain waits the eye irritation.Changes such as dendriform corneal ulcer, disciform keratitis can appear on the cornea.The cornea intuition sick for this reason characteristic sign that goes down.Herpes zoster keratitis is chickenpox---due to varicella zoster virus infects.Many sharply morbidities herpes occurs, often with General Symptomies such as neuralgia, heating, discomforts on the skin of ophthalmic branch of trigeminal nerve areal area.After invading cornea, chemosis, hyperemia, cornea intuition go down or disappear, and can occur muddiness on the cornea and soak into pathological changes, seriously can cause cornea essence diffusivity edema, can develop into disciform keratitis, secondary iridocyclitis and glaucoma.Viral keratitis is meant a kind of common external ophthalmopathy that is infected by the virus and causes, has the characteristics of showing effect repeatedly under course of disease length, the exopathogen inducement of being everlasting clinically, treats very thorny.Because being on the increase of antibiotic and antiviral drugs, though the treatment of primary disease is had very big anxiety, but still there are not ideal medicine and Therapeutic Method, so that a lot of patient's vision mission that goes down, had a strong impact on patient's life, study and work.
Summary of the invention:
Technical problem to be solved by this invention is the deficiency that overcomes prior art, and provides a kind of to eliminate patient's illness, promote physically and mentally healthy, the Chinese medicine that is used to treat keratitis that have simultaneously that medical expense is low, the patient takes medicine conveniently, curative effect is fast, has no side effect.
For solving the problems of the technologies described above, the present invention adopts following technical scheme: a kind of Chinese medicine that is used to treat keratitis, so its special character is being made up of the Chinese medicine of weight components: Radix Codonopsis 3-15 part; Faeces Passeris 2-10 part, Rhizoma Et Radix Notopterygii 3-15 part, Radix Rehmanniae 8-16 part; Folium Isatidis 3-10 part, Flos Lonicerae 3-10 part, Radix Gentianae 4-15 part; Rhizoma Chuanxiong 4-12 part, Radix Bupleuri 2-9 part.
For further solving the problems of the technologies described above, the preferred version of said medicine weight portion is: the Chinese medicine by weight components is formed: Radix Codonopsis 4-9 part, Faeces Passeris 2-7 part; Rhizoma Et Radix Notopterygii 5-10 part, Radix Rehmanniae 10-15 part, Folium Isatidis 3-7 part; Flos Lonicerae 3-8 part; Radix Gentianae 6-12 part, Rhizoma Chuanxiong 4-9 part, Radix Bupleuri 2-7 part.
For further solving the problems of the technologies described above, the preferred plan of said medicine weight portion is: the Chinese medicine by weight components is formed: 6 parts of Radix Codonopsis, 4 parts of Faeces Passeriss, 7 parts of Rhizoma Et Radix Notopterygiis; 13 parts in the Radix Rehmanniae, 5 parts of Folium Isatidiss, 5 parts of Flos Loniceraes; 9 parts of Radix Gentianaes, 6 parts of Rhizoma Chuanxiongs, 4 parts of Radix Bupleuri.
Above-mentioned described Chinese patent medicine is processed the oral medicine dosage form of pill, powder, tablet, unguentum and capsule dress powder according to the conventional technology of preparing of Chinese medicine.
The principles of formulating prescriptions of Chinese patent medicine of the present invention are: heat-clearing and toxic substances removing, mass dissipating and swelling eliminating, the wind heat of loosing.The effect of its said each herbal medicine is:
Radix Codonopsis: property is flat, sweet in the mouth, little acid.Return spleen, lung meridian.
Faeces Passeris: eliminate indigestion, removing nebula.Control the hernia abdominal mass, disease addiction, corneal nebula, bulbar conjunctiva polyp, dental caries.
Rhizoma Et Radix Notopterygii: cold expelling, dispel the wind dehumidifying, pain relieving.
The Radix Rehmanniae: sweet, cold.GUIXIN, liver, kidney channel.
Folium Isatidis: it is bright to go into foot sun, meridian of Hand-SHAO YIN.
Flos Lonicerae: the ability dispelling wind-heat, also kind removing summer-heat blood poison is used for various febrile diseases.
Radix Gentianae: nature and flavor are bitter, and are puckery, Great Cold, nontoxic.Cure mainly cold and heat between bone, frightened pathogenic factor gas, the exhausted wound that continues is decided the five internal organs, the parasite killing poison.
Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping.
Radix Bupleuri: hardship is slightly cold.Return liver, gallbladder meridian.
The clinical result of use of the Chinese medicine of treatment keratitis of the present invention shows to have following advantage:
1, the Chinese medicine each component selected for use of Chinese patent medicine of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment and the prevention keratitis disease of the Chinese medicine of respectively distinguishing the flavor of, and is harmless to human non-toxic.Acute toxicity test and accumulation toxicity test through white mice and rat show; Underproof animal does not see any toxic reaction; Compare zero difference through anatomic observation hemogram, liver function, each organs and tissues morphology finding and matched group, prove that its safety of medicine is reliable.
2, Chinese patent medicine preparation of the present invention need not decoct, not have bitterness sense; Rich in proteins, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid in the medicine; Also contain various trace elements such as Saponin, plant sterol, calcium; Help absorption of human body, health invigorating, and taking convenience.
But 3, Chinese medicinal composition preparation of the present invention efficacious therapy keratitis not only; And the preventive effect of corneal inflammation is also very obvious; Particularly pass through working in coordination with each other between the medicine, strengthen medicine and treat characteristic separately, through dredge the meridian passage and adjusting immunologic function; Improve the intrinsic healthy energy of patient body and physical and mental health and life quality, reached the healing rehabilitation efficacy preferably.
Model case is introduced:
Fang Leyuan, the man, ill toxicity keratitis in 2006, multi-treatment, but curative effect is very little, after use the treatment of this prescription promptly thoroughly to cure less than one month.
Cui Feng, the man, ill toxicity keratitis in 2000, many places treatment once all loses positive effect, after use the treatment of this pharmaceutical formulation promptly thoroughly to cure less than one month.
Yang Wei, the man, ill toxicity keratitis in 2007, the many places treatment all loses positive effect, after use the treatment of this pharmaceutical formulation promptly thoroughly to cure less than one month.
The specific embodiment
Embodiment 1
A kind of Chinese medicine that is used to treat keratitis is made up of the Chinese medicine of weight components: 3 parts of Radix Codonopsis, 2 parts of Faeces Passeriss, 3 parts of Rhizoma Et Radix Notopterygiis, 8 parts in the Radix Rehmanniae, 3 parts of Folium Isatidiss, 3 parts of Flos Loniceraes, 4 parts of Radix Gentianaes, 4 parts of Rhizoma Chuanxiongs, 2 parts of Radix Bupleuri.Process tablet according to the conventional technology of preparing of Chinese medicine.
Embodiment 2
A kind of Chinese medicine that is used to treat keratitis is made up of the Chinese medicine of weight components: 15 parts of Radix Codonopsis, 10 parts of Faeces Passeriss, 15 parts of Rhizoma Et Radix Notopterygiis, 16 parts in the Radix Rehmanniae, 10 parts of Folium Isatidiss, 10 parts of Flos Loniceraes, 15 parts of Radix Gentianaes, 12 parts of Rhizoma Chuanxiongs, 9 parts of Radix Bupleuri.Process powder according to the conventional technology of preparing of Chinese medicine.
Embodiment 3
A kind of Chinese medicine that is used to treat keratitis is made up of the Chinese medicine of weight components: 4 parts of Radix Codonopsis, 2 parts of Faeces Passeriss, 5 parts of Rhizoma Et Radix Notopterygiis, 10 parts in the Radix Rehmanniae, 3 parts of Folium Isatidiss, 3 parts of Flos Loniceraes, 6 parts of Radix Gentianaes, 4 parts of Rhizoma Chuanxiongs, 2 parts of Radix Bupleuri.Process pill according to the conventional technology of preparing of Chinese medicine.
Embodiment 4
A kind of Chinese medicine that is used to treat keratitis is made up of the Chinese medicine of weight components: 9 parts of Radix Codonopsis, 7 parts of Faeces Passeriss, 10 parts of Rhizoma Et Radix Notopterygiis, 15 parts in the Radix Rehmanniae, 7 parts of Folium Isatidiss, 8 parts of Flos Loniceraes, 12 parts of Radix Gentianaes, 9 parts of Rhizoma Chuanxiongs, 7 parts of Radix Bupleuri.Process unguentum according to the conventional technology of preparing of Chinese medicine.
Embodiment 5
A kind of Chinese medicine that is used to treat keratitis is made up of the Chinese medicine of weight components: 6 parts of Radix Codonopsis, 4 parts of Faeces Passeriss, 7 parts of Rhizoma Et Radix Notopterygiis, 13 parts in the Radix Rehmanniae, 5 parts of Folium Isatidiss, 5 parts of Flos Loniceraes, 9 parts of Radix Gentianaes, 6 parts of Rhizoma Chuanxiongs, 4 parts of Radix Bupleuri.Process capsule according to the conventional technology of preparing of Chinese medicine.

Claims (4)

1. a Chinese medicine that is used to treat keratitis is characterized in that being made up of the Chinese medicine of weight components: Radix Codonopsis 3-15 part, Faeces Passeris 2-10 part, Rhizoma Et Radix Notopterygii 3-15 part; Radix Rehmanniae 8-16 part, Folium Isatidis 3-10 part, Flos Lonicerae 3-10 part; Radix Gentianae 4-15 part, Rhizoma Chuanxiong 4-12 part, Radix Bupleuri 2-9 part.
2. the Chinese medicine that is used to treat keratitis according to claim 1 is characterized in that being made up of the Chinese medicine of weight components: Radix Codonopsis 4-9 part, Faeces Passeris 2-7 part; Rhizoma Et Radix Notopterygii 5-10 part, Radix Rehmanniae 10-15 part, Folium Isatidis 3-7 part; Flos Lonicerae 3-8 part; Radix Gentianae 6-12 part, Rhizoma Chuanxiong 4-9 part, Radix Bupleuri 2-7 part.
3. the Chinese medicine that is used to treat keratitis according to claim 1 is characterized in that being made up of the Chinese medicine of weight components: 6 parts of Radix Codonopsis, 4 parts of Faeces Passeriss, 7 parts of Rhizoma Et Radix Notopterygiis; 13 parts in the Radix Rehmanniae, 5 parts of Folium Isatidiss, 5 parts of Flos Loniceraes; 9 parts of Radix Gentianaes, 6 parts of Rhizoma Chuanxiongs, 4 parts of Radix Bupleuri.
4. according to claim 1 or the 2 or 3 described Chinese medicines that are used to treat keratitis, it is characterized in that processing the oral medicine dosage form of pill, powder, tablet, unguentum and capsule dress powder according to the conventional technology of preparing of Chinese medicine.
CN2012100907081A 2012-03-23 2012-03-23 Traditional Chinese medicine for treating keratitis Pending CN102631477A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012100907081A CN102631477A (en) 2012-03-23 2012-03-23 Traditional Chinese medicine for treating keratitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012100907081A CN102631477A (en) 2012-03-23 2012-03-23 Traditional Chinese medicine for treating keratitis

Publications (1)

Publication Number Publication Date
CN102631477A true CN102631477A (en) 2012-08-15

Family

ID=46616157

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012100907081A Pending CN102631477A (en) 2012-03-23 2012-03-23 Traditional Chinese medicine for treating keratitis

Country Status (1)

Country Link
CN (1) CN102631477A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105362484A (en) * 2015-11-25 2016-03-02 禤燕华 Traditional Chinese medicine composition for treating keratitis and preparation method thereof
CN107714729A (en) * 2017-11-20 2018-02-23 刘燕云 A kind of medicine for treating finger life snake-eye furuncle

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1768797A (en) * 2004-11-04 2006-05-10 王保安 Chinese medicine for treating star-like cataract caused by viral keratitis and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1768797A (en) * 2004-11-04 2006-05-10 王保安 Chinese medicine for treating star-like cataract caused by viral keratitis and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
刘嘉立: "中医治疗单纯疱疹病毒性角膜炎概况", 《四川中医》 *
尹安坤: "单纯疱疹性角膜炎中医药治疗进展", 《中医药临床杂志》 *
王国霞: "中西医结合治疗单纯疱疹性角膜炎疗效观察", 《中国中医眼科杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105362484A (en) * 2015-11-25 2016-03-02 禤燕华 Traditional Chinese medicine composition for treating keratitis and preparation method thereof
CN107714729A (en) * 2017-11-20 2018-02-23 刘燕云 A kind of medicine for treating finger life snake-eye furuncle

Similar Documents

Publication Publication Date Title
CN100355451C (en) Cold-treating influenza-preventing medicine
CN102755593A (en) Traditional Chinese medicine composition for treating qi goiter and preparation method thereof
CN103495042B (en) Traditional Chinese medicine composition for treating migraine
CN104547621A (en) Eye protection traditional Chinese medicine
CN102631477A (en) Traditional Chinese medicine for treating keratitis
CN102824622B (en) Preparation method of traditional Chinese medicine lotion for treating closed fracture with syndrome of palpitation
CN102793904B (en) Preparation method for traditional Chinese medicine lotion for treatment of confusing-type closed fracture
CN1160091C (en) Medicine for treating ophthalmopathy
CN104906220A (en) Traditional Chinese medicine for treating herpes zoster and herpes simplex viral keratitis
CN102631485A (en) Traditional Chinese medicine for treating keratitis
CN100490865C (en) Kidney-nourishing gout-treating capsule
CN104524524B (en) Medicine treating osteoporosis and preparing method
CN103263598B (en) Chinese medicine preparation for treating peripheral facial paralysis diseases
CN105343274A (en) Drug combination having inflammation diminishing and cough relieving functions
CN104306546A (en) A traditional Chinese medicine composition used for treating optic atrophy, and decoctions, pills and powder of the composition
CN114042109B (en) Traditional Chinese medicine composition and patch for inducing resuscitation and stopping nasal discharge, warming yang and strengthening body resistance and preparation method
CN107375551A (en) A kind of Chinese medicine composition for treating spleen type of latent damp herpes zoster
CN115300544B (en) Traditional Chinese medicine composition and patch for dispelling wind, relieving exterior syndrome, detumescence and inducing resuscitation and preparation method thereof
CN102988692A (en) Traditional Chinese medicine composition for treating herpes zoster and preparation method thereof
CN102631633B (en) Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis
CN102641409B (en) Traditional Chinese medicine for treating onychomycosis
CN1081058C (en) Chinese-medicinal band for therapy
CN103961466A (en) Oral prescription for treating xerophthalmia
CN105147909A (en) Chinese herb decoction for treating meningitis and preparation method thereof
CN105727132A (en) Traditional Chinese medicine eye drops for treating eye inflammation and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120815